Company Filing History:
Years Active: 2015-2021
Title: Joël Eyer: Innovator in Neurobiology
Introduction
Joël Eyer is a prominent inventor based in Blaison-Gohier, France. He has made significant contributions to the field of neurobiology, particularly in the development of innovative treatments for neurodegenerative disorders and brain tumors. With a total of 3 patents to his name, Eyer's work is paving the way for advancements in medical science.
Latest Patents
Eyer's latest patents include groundbreaking research on the use of a neurofilament peptide for targeting neural stem cells. This invention demonstrates that the isolated NFL-TBS peptide is highly specific for neural stem cells, making it valuable for detecting these cells in vitro or in vivo. It also has potential applications in addressing chemical compounds or biological materials to these cells, as well as treating neurodegenerative disorders or brain tumors. Another significant patent focuses on the use of the neurofilament peptide for the treatment of glioma. This invention provides a new drug to treat malignant glioma, the most prevalent type of primary tumor of the central nervous system. The NFL-TBS peptide is shown to be highly specific for glioma cells, triggering apoptosis and offering methods for detecting glioma cells in various settings.
Career Highlights
Throughout his career, Joël Eyer has worked with esteemed institutions such as the University of Angers and the National Institute of Health and Medical Research. His research has been instrumental in advancing our understanding of neurobiology and developing new therapeutic strategies.
Collaborations
Eyer has collaborated with notable professionals in his field, including Alan Peterson and Claire Lepinoux-Chambaud. These partnerships have contributed to the success of his research and the impact of his inventions.
Conclusion
Joël Eyer's innovative work in neurobiology, particularly through his patents, showcases his commitment to advancing medical science. His contributions are vital for the development of new treatments for serious health conditions, and his ongoing research promises to yield further breakthroughs in the future.